
Trump Administration's Health Report Cites Research That Doesn't Exist
Washington DC:
The US government's 'Make America Healthy Again' or MAHA commission and its chief Robert F Kennedy Jr, find themselves in an embarrassing situation after a health report it released cited "totally fabricated" research material. The report was about children's health in America.
Two versions of the report were released over the last week - the first on May 22 and the revised and updated version on May 29, but upon scrutiny, it was revealed that the studies quoted in the report, upon which their entire findings were based, were completely fabricated. This was highlighted by the academics who were wrongly listed as the authors of those studies.
The report, which was focused on the chronic disease crisis among American children, listed its causes in detail and added its findings based on studies which were "fabricated" according to academics. The updated version of the report was also found to have used seven sources which do not even exist, US' digital news outlet NOTUS said.
But the Trump Administration tried to downplay the incident by claiming that it was due to "formatting issues". White House press secretary Karoline Leavitt said that the country's top health panel - MAHA - will rework the report and share an update, but did not specify when. Moreover, she did not negate the substance of the report.
Make America Health Again was the brainchild of Robert F Kennedy Jr, and is based on Donald Trump's slogan 'Make America Great Again' or MAGA - which the Republican leader used widely during his electoral campaign, and even now as US President.
Robert F Kennedy Jr, who is the person in-charge of outlining America's health policy and outlook, is an intensely controversial figure, who has for long, promoted false claims that "autism comes from vaccines".
The research behind this week's report was being carried out by Mr Kennedy Jr's panel and was initiated after President Trump signed an executive order to "study the scope of the childhood chronic disease crisis and any potential contributing causes".
According to the BBC, the authors quoted in the studies mentioned in the government report have said, that not only have they not written them, but the studies do not even exist, to begin with.
One of the named authors, Guohua Li, a professor at Columbia University, spoke with news agency AFP, saying that the study their name is linked to is "totally fabricated" and that the co-author - Noah Kreski - whose name is mentioned along with his, is a person he has never even heard of.
When AFP contacted him, Noah Kreski, who is a researcher at Columbia University, also denied being a part of any such study, and said the same about Mr Li. He added that "It doesn't appear to be a study that exists at all."
Several other authors named in the MAHA report have similar complaints and are concerned about their names being used over fictitious studies without their knowledge. Citations are a critical part of scientific research and add authenticity and credibility to scientific findings.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scroll.in
2 hours ago
- Scroll.in
Hidden in plain sight, chronic stress is key to increased dementia and Alzheimer's risk
The probability of any American having dementia in their lifetime may be far greater than previously thought. For instance, a 2025 study that tracked a large sample of American adults across more than three decades found that their average likelihood of developing dementia between ages 55 to 95 was 42%, and that figure was even higher among women, Black adults and those with genetic risk. Now, a great deal of attention is being paid to how to stave off cognitive decline in the aging American population. But what is often missing from this conversation is the role that chronic stress can play in how well people age from a cognitive standpoint, as well as everybody's risk for dementia. We are professors at Penn State in the Center for Healthy Aging, with expertise in health psychology and neuropsychology. We study the pathways by which chronic psychological stress influences the risk of dementia and how it influences the ability to stay healthy as people age. Recent research shows that Americans who are currently middle-aged or older report experiencing more frequent stressful events than previous generations. A key driver behind this increase appears to be rising economic and job insecurity, especially in the wake of the 2007-2009 Great Recession and ongoing shifts in the labor market. Many people stay in the workforce longer due to financial necessity, as Americans are living longer and face greater challenges covering basic expenses in later life. Therefore, it may be more important than ever to understand the pathways by which stress influences cognitive aging. Social isolation and stress Although everyone experiences some stress in daily life, some people experience stress that is more intense, persistent or prolonged. It is this relatively chronic stress that is most consistently linked with poorer health. In a recent review paper, our team summarised how chronic stress is a hidden but powerful factor underlying cognitive aging, or the speed at which your cognitive performance slows down with age. It is hard to overstate the impact of stress on your cognitive health as you age. This is in part because your psychological, behavioral and biological responses to everyday stressful events are closely intertwined, and each can amplify and interact with the other. For instance, living alone can be stressful – particularly for older adults – and being isolated makes it more difficult to live a healthy lifestyle, as well as to detect and get help for signs of cognitive decline. Moreover, stressful experiences – and your reactions to them – can make it harder to sleep well and to engage in other healthy behaviors, like getting enough exercise and maintaining a healthy diet. In turn, insufficient sleep and a lack of physical activity can make it harder to cope with stressful experiences. Prevention efforts A robust body of research highlights the importance of at least 14 different factors that relate to your risk of Alzheimer's disease, a common and devastating form of dementia and other forms of dementia. Although some of these factors may be outside of your control, such as diabetes or depression, many of these factors involve things that people do, such as physical activity, healthy eating and social engagement. What is less well-recognised is that chronic stress is intimately interwoven with all of these factors that relate to dementia risk. Our work and research by others that we reviewed in our recent paper demonstrate that chronic stress can affect brain function and physiology, influence mood and make it harder to maintain healthy habits. Yet, dementia prevention efforts rarely address stress. Avoiding stressful events and difficult life circumstances is typically not an option. Where and how you live and work plays a major role in how much stress you experience. For example, people with lower incomes, less education or those living in disadvantaged neighborhoods often face more frequent stress and have fewer forms of support – such as nearby clinics, access to healthy food, reliable transportation or safe places to exercise or socialise – to help them manage the challenges of aging. As shown in recent work on brain health in rural and underserved communities, these conditions can shape whether people have the chance to stay healthy as they age. Over time, the effects of stress tend to build up, wearing down the body's systems and shaping long-term emotional and social habits. Lifestyle changes The good news is that there are multiple things that can be done to slow or prevent dementia, and our review suggests that these can be enhanced if the role of stress is better understood. Whether you are a young, midlife or an older adult, it is not too early or too late to address the implications of stress on brain health and aging. Here are a few ways you can take direct actions to help manage your level of stress: Follow lifestyle behaviors that can improve healthy aging. These include: following a healthy diet, engaging in physical activity and getting enough sleep. Even small changes in these domains can make a big difference. Prioritise your mental health and well-being to the extent you can. Things as simple as talking about your worries, asking for support from friends and family and going outside regularly can be immensely valuable. If your doctor says that you or someone you care about should follow a new health care regimen, or suggests there are signs of cognitive impairment, ask them what support or advice they have for managing related stress. If you or a loved one feel socially isolated, consider how small shifts could make a difference. For instance, research suggests that adding just one extra interaction a day – even if it's a text message or a brief phone call – can be helpful, and that even interactions with people you don't know well, such as at a coffee shop or doctor's office, can have meaningful benefits. Play Lifelong learning A 2025 study identified stress as one of 17 overlapping factors that affect the odds of developing any brain disease, including stroke, late-life depression and dementia. This work suggests that addressing stress and overlapping issues such as loneliness may have additional health benefits as well. However, not all individuals or families are able to make big changes on their own. Research suggests that community-level and workplace interventions can reduce the risk of dementia. For example, safe and walkable neighborhoods and opportunities for social connection and lifelong learning – such as through community classes and events – have the potential to reduce stress and promote brain health. Importantly, researchers have estimated that even a modest delay in disease onset of Alzheimer's would save hundreds of thousands of dollars for every American affected. Thus, providing incentives to companies who offer stress management resources could ultimately save money as well as help people age more healthfully. In addition, stress related to the stigma around mental health and aging can discourage people from seeking support that would benefit them. Even just thinking about your risk of dementia can be stressful in itself. Things can be done about this, too. For instance, normalising the use of hearing aids and integrating reports of perceived memory and mental health issues into routine primary care and workplace wellness programs could encourage people to engage with preventive services earlier. Although research on potential biomedical treatments is ongoing and important, there is currently no cure for Alzheimer's disease. However, if interventions aimed at reducing stress were prioritised in guidelines for dementia prevention, the benefits could be far-reaching, resulting in both delayed disease onset and improved quality of life for millions of people.


NDTV
4 hours ago
- NDTV
WHO Is Finalising A New Treaty To Prep For The Next Pandemic, But US Isn't Signing
On March 20, 2025, members of the World Health Organization adopted the world's first pandemic agreement, following three years of 'intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.' The U.S., however, did not participate, in part because of its intention to withdraw from the WHO. Global health experts are hailing the agreement as a historic moment. What does the agreement mean for the world, and how can it make everyone safer and more prepared for the next pandemic? The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, and the significance of the U.S.'s absence from it. What will the pandemic agreement do? The accord will bolster pandemic preparation within individual countries and around the world. Countries signing onto the agreement are committing to improve their disease surveillance and grow their heath care workforces, strengthen their regulatory systems and invest in research and development. It encourages countries to strengthen their health regulations and infrastructure, improve communication with the public about pandemics and increase funding for preparation and response efforts. It also includes new mechanisms for producing and distributing vaccines and other essential countermeasures. Finally, it encourages countries to coordinate their responses and share information about infectious diseases and intellectual property so that vaccines and other essential countermeasures can be made available more quickly. The agreement will take effect once enough countries ratify it, which may take several years. Why isn't the US involved? The Biden administration was broadly supportive of a pandemic agreement and was an active participant in negotiations. Prior to Donald Trump's reelection, however, Republican governors had signed a letter opposing the treaty, echoing a conservative think tank's concerns about U.S. sovereignty. The U.S. withdrew from negotiations when President Trump signed an executive order to withdraw from the WHO on the day he was inaugurated for his second term. Why could the lack of US involvement be beneficial for the world? The lack of U.S. involvement likely resulted in a much more equitable treaty, and it is not clear that countries could have reached an agreement had the U.S. continued to object to key provisions. It was only once the U.S. withdrew from the negotiations that an agreement was reached. The U.S. and several other wealthy countries were concerned with protecting their pharmaceutical industry's profits and resisted efforts aimed at convincing pharmaceutical companies to share the knowledge, data and intellectual property needed for producing new vaccines and other essential countermeasures. Other negotiators sought greater access to vaccines and other treatments during a pandemic for poorer countries, which often rely on patented technologies from global pharmaceutical companies. While most people in wealthy countries had access to COVID-19 vaccines as early as 2021, many people in developing countries had to wait years for vaccines. How could the agreement broaden access for treatments? One of the contentious issues in the pandemic agreement has to do with how many vaccines manufacturers in each country must share in exchange for access to genetic sequences to emerging infectious diseases. Countries are still negotiating a system for sharing the genetic information on pathogens in return for access to vaccines themselves. It is important that researchers can get these sequences to make vaccines. And, of course, people need access to the vaccines once they are developed. Still, there are many more promising aspects of the agreement for which no further negotiations are necessary. For instance, the agreement will increase global vaccine supply by increasing manufacturing around the world. The agreement also specifies that countries and the WHO should work together to create a mechanism for fairly sharing the intellectual property, data and knowledge needed to produce vaccines and other essential health products. If financing for new innovation requires equitable access to the new technologies that are developed, many people in poor countries may get access to vaccines much more quickly in the next pandemic. The agreement also encourages individual countries to offer sufficient incentives for pharmaceutical companies to extend access to developing countries. If countries implement these changes, that will benefit people in rich countries as well as poor ones. A more equitable distribution of vaccines can contain the spread of disease, saving millions of lives. What more should be done, and does the US have a role to play? In my view, the best way to protect public health moving forward is for countries to sign on to the agreement and devote more resources to global health initiatives. This is particularly important given declining investment and participation in the WHO and the contraction of other international health initiatives, such as USAID. Without international coordination, it will become harder to catch and address problems early enough to prevent epidemics from becoming pandemics. It will also be imperative for member countries to provide funding to support the agreement's goals and secure the innovation and access to new technologies. This requires building the basic health infrastructure to ensure shots can get into people's arms.

Mint
5 hours ago
- Mint
Explainer: What is agro-terrorism and fusarium graminearum threat fueling the US-China tensions?
The recent arrest of a Chinese researcher and charges against another for smuggling a dangerous crop-killing fungus into the United States have brought renewed attention to the threat of agro-terrorism. At the heart of the case is Fusarium graminearum, a potent plant pathogen capable of devastating cereal crops and disrupting national food supplies. US officials allege the two researchers, one of whom worked at a University of Michigan lab, intended to conduct unauthorized research on the fungus—raising fears of deliberate attempts to compromise American agriculture. The incident, unfolding amid heightened US-China tensions and trade disputes, highlights how scientific collaboration can be exploited to target a country's most vulnerable infrastructure: its food system. What is agro-terrorism? Agro-terrorism is the intentional use of biological agents—such as plant pathogens, pests, or contaminants—to attack a country's agricultural infrastructure. It targets food production systems with the aim of causing economic devastation, food insecurity, and public panic. Agro-terrorism is attractive to hostile actors because it is low-cost, difficult to detect, and capable of triggering far-reaching economic and social damage. Why agriculture is a soft target Agriculture-based sectors are especially vulnerable. Unlike military or financial systems, farms, food processing plants, and supply chains are less protected and widely dispersed. Biological attacks on crops or livestock can go undetected for weeks and are difficult to trace back to the perpetrators. This makes agro-terrorism a potent weapon for countries or groups seeking to destabilize a rival nation. Fusarium graminearum: A potent agro-terrorism threat At the center of the current controversy is Fusarium graminearum, a fungus that causes Fusarium head blight—a disease that ravages cereal crops such as wheat, barley, maize, and rice. The fungus not only decimates yields but also produces a toxin called vomitoxin (deoxynivalenol), making the grain unsafe for human and animal consumption. According to the US Department of Agriculture, this disease causes over $1 billion in crop losses annually in the United States alone. Vomitoxin can cause vomiting, diarrhea, abdominal pain, and fever in livestock and people, further amplifying its public health impact. The case: Chinese researchers charged Two Chinese nationals, Yunqing Jian (33) and Zunyong Liu (34), have been charged by US federal prosecutors with smuggling Fusarium graminearum into the United States—without proper permits and under false pretenses. Jian, who works at the University of Michigan, is currently in US custody. Liu, her boyfriend and a researcher in China, is believed to be in China and remains at large. According to the FBI, Liu carried baggies of the fungus into the US via the Detroit airport and initially lied about them. He later admitted he intended to use them for research in a Michigan lab. Jian allegedly received Chinese government funding for similar research and has expressed loyalty to the Chinese Communist Party (CCP). US Attorney Jerome Gorgon Jr. described the smuggling as a 'national security' concern, emphasizing the CCP ties and the threat to America's food supply. Why this matters Although Fusarium graminearum already exists in the US, the unauthorised import of foreign strains is dangerous. Variants may be more virulent, pesticide-resistant, or adapted to new climates—making them harder to contain. Bringing them in without the proper biosecurity controls risks new outbreaks or genetic mutations that existing defenses can't manage. FBI Director Kash Patel warned that this could have "grave consequences... putting American lives and our economy at serious risk." He emphasised that this case illustrates how state-backed actors may attempt to infiltrate US institutions and compromise critical sectors like food security. Wider context: US-China tensions This incident comes amid deteriorating relations between Washington and Beijing. US-China trade talks stall after Geneva tariff truce Trade negotiations between the United States and China have stalled, just weeks after both sides agreed in Geneva to a 90-day cooling-off period by reducing tariffs. The agreement had seen China cut tariffs on American goods from 125% to 10%, while the U.S. proposed lowering its tariffs on Chinese imports from 145% to 30%. However, progress has faltered amid renewed tensions. U.S. President Donald Trump reignited the dispute on May 30, accusing China of 'totally violating' the Geneva deal, though he did not provide specifics. 'So much for being Mr. NICE GUY!' he wrote on social media. In response, China's Commerce Ministry denied any violations and accused Washington of making 'bogus charges' and taking 'unreasonable' actions, including export controls on AI chips and revoking Chinese student visas. The Trump administration has also recently announced a crackdown on Chinese student visas, citing national security threats. US Secretary of State Marco Rubio pledged to 'aggressively revoke' visas for Chinese students in sensitive research fields—moves Beijing has denounced as 'discriminatory.'